• Executive Summary o Market Overview • Market Landscape o Market ecosystem o Value chain analysis • Market Sizing o Market definition o Market segment analysis o Market size 2020 o Market outlook: Forecast for 2020 - 2025 • Five Forces Analysis o Five forces summary o Bargaining power of buyers o Bargaining power of suppliers o Threat of new entrants o Threat of substitutes o Threat of rivalry o Market condition • Market Segmentation by Application o Market segments o Comparison by Application o In-vitro diagnostics - Market size and forecast 2020-2025 o Pharmaceutical research - Market size and forecast 2020-2025 o Drug delivery services - Market size and forecast 2020-2025 o Market opportunity by Application • Customer landscape • Geographic Landscape o Geographic segmentation o Geographic comparison o North America - Market size and forecast 2020-2025 o Europe - Market size and forecast 2020-2025 o APAC - Market size and forecast 2020-2025 o South America - Market size and forecast 2020-2025 o MEA - Market size and forecast 2020-2025 o Key leading countries o Market opportunity By Geographical Landscape o Market drivers o Market challenges o Market trends • Vendor Landscape o Overview o Vendor landscape o Landscape disruption • Vendor Analysis o Vendors covered o Market positioning of vendors o Agilent Technologies Inc. o Bio Rad Laboratories Inc. o Biocartis Group NV o BioFluidix GmbH o Danaher Corp. o Fluigent SA o General Electric Co. o PerkinElmer Inc. o QIAGEN NV o uFluidix Inc. • Appendix o Scope of the report o Currency conversion rates for US$ o Research methodology o List of abbreviations Exhibits Exhibits1: Key Finding 1 Exhibits2: Key Finding 2 Exhibits3: Key Finding 3 Exhibits4: Key Finding 5 Exhibits5: Key Finding 6 Exhibits6: Key Finding 7 Exhibits7: Key Finding 8 Exhibits8: Parent market Exhibits9: Market characteristics Exhibits10: Offerings of vendors included in the market definition Exhibits11: Market segments Exhibits12: Global - Market size and forecast 2020 - 2025 ($ million) Exhibits13: Global market: Year-over-year growth 2020 - 2025 (%) Exhibits14: Five forces analysis 2020 & 2025 Exhibits15: Bargaining power of buyers Exhibits16: Bargaining power of suppliers Exhibits17: Threat of new entrants Exhibits18: Threat of substitutes Exhibits19: Threat of rivalry Exhibits20: Market condition - Five forces 2020 Exhibits21: Application - Market share 2020-2025 (%) Exhibits22: Comparison by Application Exhibits23: In-vitro diagnostics - Market size and forecast 2020-2025 ($ million) Exhibits24: In-vitro diagnostics - Year-over-year growth 2020-2025 (%) Exhibits25: Pharmaceutical research - Market size and forecast 2020-2025 ($ million) Exhibits26: Pharmaceutical research - Year-over-year growth 2020-2025 (%) Exhibits27: Drug delivery services - Market size and forecast 2020-2025 ($ million) Exhibits28: Drug delivery services - Year-over-year growth 2020-2025 (%) Exhibits29: Market opportunity by Application Exhibits30: Customer landscape Exhibits31: Market share By Geographical Landscape 2020-2025 (%) Exhibits32: Geographic comparison Exhibits33: North America - Market size and forecast 2020-2025 ($ million) Exhibits34: North America - Year-over-year growth 2020-2025 (%) Exhibits35: Europe - Market size and forecast 2020-2025 ($ million) Exhibits36: Europe - Year-over-year growth 2020-2025 (%) Exhibits37: APAC - Market size and forecast 2020-2025 ($ million) Exhibits38: APAC - Year-over-year growth 2020-2025 (%) Exhibits39: South America - Market size and forecast 2020-2025 ($ million) Exhibits40: South America - Year-over-year growth 2020-2025 (%) Exhibits41: MEA - Market size and forecast 2020-2025 ($ million) Exhibits42: MEA - Year-over-year growth 2020-2025 (%) Exhibits43: Key leading countries Exhibits44: Market opportunity By Geographical Landscape ($ million) Exhibits45: Impact of drivers and challenges Exhibits46: Vendor landscape Exhibits47: Landscape disruption Exhibits48: Industry risks Exhibits49: Vendors covered Exhibits50: Market positioning of vendors Exhibits51: Agilent Technologies Inc. - Overview Exhibits52: Agilent Technologies Inc. - Business segments Exhibits53: Agilent Technologies Inc. - Key offerings Exhibits54: Agilent Technologies Inc. - Key customers Exhibits55: Agilent Technologies Inc. - Segment focus Exhibits56: Bio Rad Laboratories Inc. - Overview Exhibits57: Bio Rad Laboratories Inc. - Business segments Exhibits58: Bio Rad Laboratories Inc. - Key offerings Exhibits59: Bio Rad Laboratories Inc. - Key customers Exhibits60: Bio Rad Laboratories Inc. - Segment focus Exhibits61: Biocartis Group NV - Overview Exhibits62: Biocartis Group NV - Business segments Exhibits63: Biocartis Group NV - Key offerings Exhibits64: Biocartis Group NV - Key customers Exhibits65: Biocartis Group NV - Segment focus Exhibits66: BioFluidix GmbH - Overview Exhibits67: BioFluidix GmbH - Product and service Exhibits68: BioFluidix GmbH - Key offerings Exhibits69: BioFluidix GmbH - Key customers Exhibits70: BioFluidix GmbH - Segment focus Exhibits71: Danaher Corp. - Overview Exhibits72: Danaher Corp. - Business segments Exhibits73: Danaher Corp. - Key offerings Exhibits74: Danaher Corp. - Key customers Exhibits75: Danaher Corp. - Segment focus Exhibits76: Fluigent SA - Overview Exhibits77: Fluigent SA - Product and service Exhibits78: Fluigent SA - Key offerings Exhibits79: Fluigent SA - Key customers Exhibits80: Fluigent SA - Segment focus Exhibits81: General Electric Co. - Overview Exhibits82: General Electric Co. - Business segments Exhibits83: General Electric Co. - Key offerings Exhibits84: General Electric Co. - Key customers Exhibits85: General Electric Co. - Segment focus Exhibits86: PerkinElmer Inc. - Overview Exhibits87: PerkinElmer Inc. - Business segments Exhibits88: PerkinElmer Inc. - Key offerings Exhibits89: PerkinElmer Inc. - Key customers Exhibits90: PerkinElmer Inc. - Segment focus Exhibits91: QIAGEN NV - Overview Exhibits92: QIAGEN NV - Business segments Exhibits93: QIAGEN NV - Key offerings Exhibits94: QIAGEN NV - Key customers Exhibits95: QIAGEN NV - Segment focus Exhibits96: uFluidix Inc. - Overview Exhibits97: uFluidix Inc. - Product and service Exhibits98: uFluidix Inc. - Key offerings Exhibits99: uFluidix Inc. - Key customers Exhibits100: uFluidix Inc. - Segment focus Exhibits101: Currency conversion rates for US$ Exhibits102: Research Methodology Exhibits103: Validation techniques employed for market sizing Exhibits104: Information sources Exhibits105: List of abbreviations

Agilent Technologies Inc., Bio Rad Laboratories Inc., Biocartis Group NV, BioFluidix GmbH, Danaher Corp., Fluigent SA, General Electric Co., PerkinElmer Inc., QIAGEN NV, uFluidix Inc.